<bill session="115" type="s" number="1003" updated="2017-09-11T02:59:59Z">
  <state datetime="2017-05-02">REFERRED</state>
  <status>
    <introduced datetime="2017-05-02"/>
  </status>
  <introduced datetime="2017-05-02"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title XIX of the Social Security Act to add standards for drug compendia for physician use for purposes of Medicaid payment for certain drugs, and for other purposes.</title>
    <title type="display">A bill to amend title XIX of the Social Security Act to add standards for drug compendia for physician use for purposes of Medicaid payment for certain drugs, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="G000386"/>
  <cosponsors>
    <cosponsor bioguide_id="C001070" joined="2017-05-02"/>
  </cosponsors>
  <actions>
    <action datetime="2017-05-02">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-05-02" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Health information and medical records"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2017-05-02T04:00:00Z" status="Introduced in Senate">This bill amends titles XVIII (Medicare) and XIX (Medicaid) of the Social Security Act to add standards for drug compendia&#160;used by physicians with respect to&#160;payment for certain drugs under the Medicare and Medicaid programs.

Specifically, such compendia shall include compendia that, as determined by the Centers for Medicare &amp; Medicaid Services: (1) are used by health care providers and&#160;utilized nationwide by the health insurance industry, (2) have a publicly available policy on disclosures of conflicts of interest,&#160; and (3) are accepted by at least one state board of pharmacy or equivalent licensing body.</summary>
  <committee-reports/>
</bill>
